We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- Dendritic cells: A brief history
- Dendritic cells: Bridging innate and adaptive immunity
- The monocyte: A progenitor of dendritic cells
- Dendritic cells differentiate via either the myeloid or lymphoid pathways
- Classification of dendritic cell subsets
- Plasmacytoid dendritic cells
- Type I interferons in innate and adaptive immunity
- Conventional dendritic cells
- Mechanisms of antigen acquisition
- Antigen processing via the endocytic pathway
- Division of labour between DC subsets
- cDC1 dendritic cells are responsible for cell mediated immunity
- Mechanisms of antigen cross-presentation
- Dendritic cell maturation
- Dendritic cell migration
- Signals for naïve T cell activation
- The immunological synapse
- Dendritic cells guide T cell commitment
- The outcomes of DC-T cell interactions
- Homeostatic expansion: Proliferation without activation
- The thymus: A site of central tolerance
- Clonal deletion of self-reactive thymocytes
- The quest for a subset of tolerogenic DCs
- Induction of Treg cells
- Mechanism of action of Treg cells
- Therapeutic use of dendritic cells
- Cancer immunotherapy
- Clinical trials of cancer immunotherapy
- Induction of tolerance in a clinical context
- Summary
Topics Covered
- Differentiation of dendritic cells from hematopoietic progenitors
- Classification of dendritic cell subsets
- Dendritic cell maturation and migration patterns
- Outcomes of DC-T cell interactions
- The therapeutic use of dendritic cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fairchild, P.J. (2021, April 28). Dendritic cells: professional antigen presenting cells [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/DHQW3623.Export Citation (RIS)
Publication History
Financial Disclosures
- Professor Fairchild is a deputy editor of the Journal of Immunology and Regenerative Medicine. He also receives grants from the UCSF, Rosetrees Trust and EPA Trust. He has two patents licensed by OxVax Ltd. He has shares in OxVax Ltd as Founding Director.
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Paul Fairchild and I'm based at the Sir William Dunn School of
Pathology at Oxford University, where I'm also a fellow of Trinity College.
What I want to do is to give you a broad overview in this lecture of
a particular cell type which is absolutely crucial to the immune system,
and that is, of course, the dendritic cell.
The reason that dendritic cells are so critical
to the immune system is that all immune responses,
whether protective or pathogenic in their own right,
are initiated by the presentation of antigen to naive T-cells by dendritic cells.
But dendritic cells are also a cell type which is very close to my own heart
because I first encountered them as a PhD student back in the late 1980s,
and I've been studying their properties, on and off, pretty much ever since.
I've spent many happy hours in the presence of dendritic cells.
0:54
Let me begin by giving you a little historical perspective.
Dendritic cells were first discovered back in the early 1970s by Ralph Steinman and
Zanvil Cohn as a unique population of
leucocytes in the spleens and the lymph nodes of mice.
It was that observation which earned
Ralph Steinman the Nobel Prize for Medicine or Physiology back in 2011,
which was something of a bitter-sweet award.
He sadly died just two days before the award was announced,
and so never knew that he'd been awarded the Nobel Prize.
Nevertheless, his name will always be associated with
dendritic cells, and his contribution to immunology will always be acknowledged.
He was the first to call these cells
dendritic cells in recognition of their very complex morphology,
but also to reflect the fact that they can interdigitate among
naive T-cells in the secondary lymphoid tissues to form quite complex clusters of cells,
and you can see some of these in this photomicrograph.
Although he worked with Zanvil Cohn, particularly on macrophages,
it soon became clear that dendritic cells can be
distinguished from macrophages on a number of different bases.
First of all they constitutively express MHC class II molecules, but more importantly,
they have the unique capacity to stimulate antigen-naive T-cells
in an assay which has since become known as the 'mixed leukocyte reaction'.
Macrophages in that same assay fail completely to
stimulate naive T-cells, and fail to induce their proliferation.
Dendritic cells are unique when measured via the mixed leukocyte reaction.
Although dendritic cells were first discovered as
that population in the secondary lymphoid tissues of mice,
they were subsequently found to be distributed throughout
all interstitial tissues and peripheral organs of the body in an immature form,
where they serve as 'sentinels' of the immune system.
They have that capacity to sense the presence of
infectious microorganisms within the local vicinity.
Quite how these cells in peripheral tissues are related to the cells originally
identified by Ralph Steinman in
the secondary lymphoid tissues has only become clear in recent years,
but it's a journey of discovery that has helped us understand how
these cells help to bridge so effectively, innate and adaptive immunity.
The ability of dendritic cells to span these two arms of